Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

E

EY

@EY
Manufacturer
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
About
Posts
3
Topics
3
Shares
0
Groups
1
Followers
1
Following
0

Posts

Recent Best Controversial

  • Common design/copy - one submission for multiple websites?
    E EY

    We would like to implement a new HCP gating mechanism across several of our websites. For efficiency, is there a process to have one submission of the design and copy of this HCP gating mechanism (that would be consistently applied across multiple websites) instead of separate submissions for each website?

    PAAB Code

  • Spelling errors found after PAAB approval
    E EY

    We would like to correct a spelling and grammatical error that was found after PAAB approval was received. Are we able to make the change and provide notice to PAAB without requiring another submission?

    FYI post-approval change/preclearance exemption/what requires review/PAAB scope

  • Contextual Use of a Healthcare Product Name
    E EY

    Regarding Section 1.5 of the PAAB Code – Materials Not Subject to Preclearance, Section D provides examples (i to v) of contextual use of a healthcare product name. Is this an exhaustive list? If we were to have a different example (not represented on the list) where the healthcare product name was used in a context not linked to therapeutic or promotional messages, could it also be considered not subject to preclearance?

    FYI post-approval change/preclearance exemption/what requires review/PAAB scope
  • Login

  • Don't have an account? Register

  • Login or register to search.
  • First post
    Last post
0
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups